Overview
The study is a prospective registration of treatment related-, toxicity-, Quality of lifeand outcome data from patients treated in Denmark with radiotherapy for squamous cell carcinoma of the anus (SCCA), as a cooperation within the Danish Anal Cancer Group (DACG).
Substudy one: A prospective biobank is collected with the purpose to identify predictive and prognostic markers for outcome.
Substudy two: MRI scans are performed to investigate the rate of pelvic insufficience fractures at one year post chemoradiotherapy.
Eligibility
Inclusion Criteria:
- Age ≥ 18
- Squamous cell carcinoma of the anus, and indication for curatively intended radiotherapy
- Written and oral consent
Exclusion Criteria:
- Contraindication to blood sampling or MRI scans (substudy 1 and 2)
- Other malignant disease within 5 years except from basal cell carcinomas